GLTO

Galecto, Inc.

Latest Form 4:Sale$5KbyWinslow Garrett (General Counsel) · filed Jan 6, 2026

Galecto, Inc. (GLTO) has 7 SEC Form 4 filings (11 transaction rows) in the rolling window, disclosed by 3 distinct insiders. Most recent filing: Feb 12, 2026.

  • Industry:Medical - Pharmaceuticals
  • CEO:Jennifer A. Jarrett
  • Employees:7
  • HQ:Boston, MA, US
  • IPO:2020-10-28

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$23K

reported sales (SEC code S)

Unique Insiders

3

in the rolling window

Source
Winslow GarrettFirst filing
Sale$5KJan 6SEC ↗
Firmani LoriFirst filing
Sale$3KJan 6SEC ↗
Schambye Hans T.First filing
Sale$15KJan 6SEC ↗